All Posts By

Smartkarma Daily Briefs

Daily Brief Health Care: Shanghai Henlius Biotech , Dr Agarwal’s Health Care Ltd, Alteogen Inc, Cardinal Health, Resmed Inc, Thermo Fisher Scientific Inc and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Shanghai Henlius Biotech (2696 HK) – LVC Increased Its Holding of Henlius Again
  • Dr Agarwal’s Healthcare IPO Trading – Decent Anchor Demand but Subdued Overall Coverage
  • Alteogen (196170 KS): More ALT-B4 Licensing Deal to Follow; Fund Raise Wipes Off Uncertainty
  • Cardinal Health: Expanding Specialty Services To Change The Game! – Major Drivers
  • ResMed: How Sleep Apnea Awareness is Expanding Global Market Potential! – Major Drivers
  • Thermo Fisher Scientific: Will Its Shift Toward Contract Research and Manufacturing Pay Off? – Major Drivers


Shanghai Henlius Biotech (2696 HK) – LVC Increased Its Holding of Henlius Again

By Xinyao (Criss) Wang

  • LVC increased its holding of Henlius by 1,110,900 shares on January 23, reflecting its high recognition of the Company and optimism on its prospects, despite the biosimilar VBP headwinds.
  • Even with concerns, LVC still repeatedly invested in Henlius at a valuation far higher than its actual value, offering support with real money during pre-IPO stage.
  • Lin Lijun’s dissenting vote was a deliberate decision. We are interested to see Lin’s next move. Lin should have a very clear understanding of the true value of Henlius.

Dr Agarwal’s Healthcare IPO Trading – Decent Anchor Demand but Subdued Overall Coverage

By Akshat Shah

  • Dr Agarwal’s Health Care Ltd (8140044Z IN) raised around US$350m in its India IPO.
  • Dr Agarwal’s Health Care is a healthcare/hospital chain in India providing eyecare services, including surgeries; consultations, diagnoses, non-surgical treatments; and sells opticals, contact lens, accessories and eyecare related pharmaceutical products.
  • We have looked at the company’s past performance and valuations in our previous notes. In this note, we will talk about the trading dynamics.

Alteogen (196170 KS): More ALT-B4 Licensing Deal to Follow; Fund Raise Wipes Off Uncertainty

By Tina Banerjee

  • In November 2024, Alteogen Inc (196170 KS) entered into an exclusive license agreement with Daiichi Sankyo for an upfront payment of $20M (KRW28B).
  • With increasing number of players developing ADC drugs mainly targeting various cancers, we can expect more big-ticket licensing deals for ALT-B4, going ahead.
  • On February 4, Alteogen has raised ~KRW155B through redeemable convertible preference shares. Over the last few months, Alteogen shares had a roller coaster ride due to fund raising rumors.

Cardinal Health: Expanding Specialty Services To Change The Game! – Major Drivers

By Baptista Research

  • Cardinal Health, Inc.’s recent financial results offer a multifaceted view of the company’s current position and future potential in the healthcare industry.
  • The company showcased strong performance in certain areas while facing challenges in others, leading to a complex investment outlook.
  • A significant highlight from the results was the robust performance of the Pharmaceutical and Specialty Solutions segment.

ResMed: How Sleep Apnea Awareness is Expanding Global Market Potential! – Major Drivers

By Baptista Research

  • ResMed Inc.’s second quarter fiscal year 2025 earnings presentation highlights several notable financial and operational results, alongside key strategic initiatives.
  • From a performance standpoint, the company reported a global revenue increase of 10%, reaching $1.28 billion.
  • This growth spanned ResMed’s key business sectors, including device sales, which rose by 11%, and masks and accessories, which grew by 11% as well.

Thermo Fisher Scientific: Will Its Shift Toward Contract Research and Manufacturing Pay Off? – Major Drivers

By Baptista Research

  • For the fourth quarter of 2024, Thermo Fisher Scientific reported a 5% year-over-year growth in revenue, reaching $11.4 billion, alongside a 7% increase in adjusted operating income, which totaled $2.72 billion.
  • This resulted in an adjusted operating margin expansion by 50 basis points to 23.9%.
  • Moreover, adjusted earnings per share (EPS) grew by 8% to $6.10.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Grab Holdings , IWG PLC, Northrop Grumman, United Parcel Service Cl B, Takara Standard, Daiichi Jitsugyo, Caterpillar Inc, Parker Hannifin, Roper Technologies, Alinco Inc and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Grab Holdings (GRAB US) – GoTo Merger Rears Its Head?
  • 1 Main Capital’s Yaron Naymark on some general investor skepticism with $IWG.L thesis
  • Northrop Grumman: Does Its Role in National Security Really Shield It From Market Volatility? – Major Drivers
  • United Parcel Service (UPS): International Diversification to Capitalize On Emerging Trades! – Major Drivers
  • Takara Standard (7981 JP): Q3 FY03/25 flash update
  • Daiichi Jitsugyo (8059 JP): Q3 FY03/25 flash update
  • Caterpillar Inc.: An Insight Into Its Pricing Strategies & Market Conditions! – Major Drivers
  • Parker Hannifin: How the Meggitt Acquisition Reshapes Its Aerospace Business! – Major Drivers
  • Roper Technologies: How a Software-First Strategy is Reshaping Growth! – Major Drivers
  • Alinco Inc (5933 JP): Q3 FY03/25 flash update


Grab Holdings (GRAB US) – GoTo Merger Rears Its Head?

By Angus Mackintosh

  • Press reports suggest that a merger between GoTo Gojek Tokopedia and Grab is back on the table, which is ironic given the progress of both companies towards profitability. 
  • Any merger may encounter anti-trust issues in Indonesia, with some fallout for drivers and potentially merchants, which may encounter resistance from the government and even potential demonstrations but not insurmountable.
  • Grab should book a net profit in 2025 plus higher growth, as its barbell strategy gains traction, but a GoTo merger could move the dial towards much higher profitability.

1 Main Capital’s Yaron Naymark on some general investor skepticism with $IWG.L thesis

By Yet Another Value Podcast

  • IWG is the largest co working flex office company in the world, with brands like Regus, Spaces, HQ signature and The Lights
  • The company has been profitable and has grown through a capital light strategy of managed and franchise models
  • The stock is currently undervalued, with potential for significant growth in earnings and free cash flow from the managed business in the upcoming years

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Northrop Grumman: Does Its Role in National Security Really Shield It From Market Volatility? – Major Drivers

By Baptista Research

  • Northrop Grumman reported its fourth-quarter and full-year 2024 financial results, showcasing both achievements and challenges.
  • The company ended the year with a record backlog of approximately $91.5 billion and a book-to-bill ratio of 1.23x, indicating strong demand in both domestic and international markets.
  • This demand is supported by new contract wins, such as the TACAMO program and the B-21’s second LRIP Lot, as well as ongoing programs like Poland’s IBCS system, which contributes to an international book-to-bill ratio of 1.4x.

United Parcel Service (UPS): International Diversification to Capitalize On Emerging Trades! – Major Drivers

By Baptista Research

  • United Parcel Service, Inc. (UPS) delivered a mixed fourth-quarter 2024 performance, reflecting strategic operational adjustments and market challenges.
  • Highlighting a slight revenue growth with significant profit and margin expansion, UPS navigated the complexities of a shifting logistics landscape while undergoing significant operational transformations.
  • UPS reported a consolidated revenue increase of 1.5% year-over-year to $25.3 billion for Q4 2024.

Takara Standard (7981 JP): Q3 FY03/25 flash update

By Shared Research

  • Revenue reached JPY184.3bn (+2.7% YoY) and operating profit JPY12.9bn (+20.1% YoY), driven by strong new housing sales.
  • Cumulative Q3 revenue achieved 77.1% of FY03/25 forecast, with operating profit at 88.8% and net income at 93.3%.
  • New housing complex market revenue grew 12.0% YoY, while remodeling market revenue declined 5.2% YoY.

Daiichi Jitsugyo (8059 JP): Q3 FY03/25 flash update

By Shared Research

  • In cumulative Q3 FY03/25, orders were JPY155.9bn (-0.7% YoY), revenue JPY160.8bn (+36.9% YoY), net income JPY7.3bn.
  • Revenue increased due to higher sales in plant equipment, lithium-ion battery manufacturing, and molding machines, boosting operating profit.
  • Orders and revenue rose in automotive, medical device, and airline equipment sectors, leading to significant operating profit growth.

Caterpillar Inc.: An Insight Into Its Pricing Strategies & Market Conditions! – Major Drivers

By Baptista Research

  • Caterpillar Inc.’s performance for the fourth quarter and the entire year of 2024 demonstrates a mixed set of outcomes, underscoring both the strengths and challenges faced by the company.
  • The diversified nature of its end markets and its sustained focus on long-term strategic goals have been pivotal in maintaining a relatively stable financial position despite a decrease in top-line results.
  • Positively, Caterpillar reported a record adjusted profit per share for the year at $21.90, a 3% increase over 2023, and achieved an adjusted operating profit margin of 20.7%.

Parker Hannifin: How the Meggitt Acquisition Reshapes Its Aerospace Business! – Major Drivers

By Baptista Research

  • Parker-Hannifin Corporation recently reported its fiscal 2025 second-quarter results, showcasing both commendable achievements and areas for improvement.
  • The company demonstrated strong operational excellence despite facing some top-line pressures and a slightly challenging market environment.
  • Notably, Parker-Hannifin achieved record second-quarter adjusted segment operating margins of 25.6%, marking a 110 basis point improvement year-over-year.

Roper Technologies: How a Software-First Strategy is Reshaping Growth! – Major Drivers

By Baptista Research

  • Roper Technologies delivered a strong financial performance in the fourth quarter and full year 2024, characterized by significant revenue and cash flow growth.
  • For the year, the company achieved a 14% revenue increase, driven by equal contributions from organic expansion and strategic acquisitions.
  • Roper demonstrated robust cash flow generation with a 16% year-over-year increase in free cash flow, reaching over $2 billion, while maintaining impressive free cash flow margins of 32%.

Alinco Inc (5933 JP): Q3 FY03/25 flash update

By Shared Research

  • Revenue reached JPY47.2bn (+5.6% YoY), operating profit JPY2.0bn (+6.7% YoY), recurring profit JPY2.6bn (-5.5% YoY).
  • Revenue for construction materials was JPY19.1bn (+16.0% YoY), segment profit JPY1.9bn (-5.9% YoY) due to higher costs.
  • Revenue for low-power radios was JPY3.7bn (-7.2% YoY), segment loss JPY444mn due to lower sales and higher expenses.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Toc Co Ltd, Samsung Fire & Marine Insurance, Religare Enterprises, CSI Properties, Hana Financial, Marsh & Mclennan, Chesapeake Financial Shares In and more

By | Daily Briefs, Financials

In today’s briefing:

  • TOC (8841) Buyback Makes One Wonder When The Takeout Comes
  • Samsung Life Insurance Is Considering on Incorporating Samsung F&M Insurance as a Subsidiary
  • The Religare Controversy: A Corporate Battle
  • Asia Real Estate Tracker (04-Feb-2025): Gaw Capital raises $260M for HK’s CSI Properties.
  • Hana Financial: Share Buyback and Cancellation of 400 Billion Won + 50% Total Shareholder Return
  • Marsh McLennan: Can Insurance Pricing Cycles Sustain Growth in the Long Run? – Major Drivers
  • CPKF: Fourth Diluted Quarter EPS beats Our Estimate by a Dime


TOC (8841) Buyback Makes One Wonder When The Takeout Comes

By Travis Lundy

  • 7 years ago I wrote a big piece titled TOC’s BIGLY Buyback Makes It a Takeout Target. I thought the shareholder structure and buyback plans looked like a creeping takeover. 
  • In December 2017, Effissimo had sold a very large stake back to the company. I wrote in March 2018. 10mos later they did another and I wrote again.
  • Since then they’ve bought back a bit more. Today they are buying back another 5%. It still looks like a potential takeover.

Samsung Life Insurance Is Considering on Incorporating Samsung F&M Insurance as a Subsidiary

By Douglas Kim

  • After the market close on 4 February, several local news outlets reported that Samsung Life Insurance is considering on incorporating Samsung Fire & Marine Insurance as a subsidiary.
  • Share cancellation by Samsung F&M Insurance would lead to an increase in ownership stake of Samsung F&M Insurance by Samsung Life Insurance which would violate the current Insurance Business Act. 
  • It is unlikely for Samsung Life Insurance to sell some of its stake in Samsung F&M Insurance, but Samsung Life Insurance could increase its stake in Samsung F&M Insurance.

The Religare Controversy: A Corporate Battle

By Nimish Maheshwari

  • Religare Enterprises (RELG IN)’s saga intensifies as CEO Rashmi Saluja sues her own company amid takeover bids by the Burman family, amid insider trading allegations.
  • The battle, initially a takeover bid, has evolved into an ED probe, halting shareholder meetings and raising serious governance concerns.
  • Everything lies in the hands of Religare’s shareholder since to gain the helm again Rashmi needs more than 50% votes in the upcoming meeting on 7-Feb.

Asia Real Estate Tracker (04-Feb-2025): Gaw Capital raises $260M for HK’s CSI Properties.

By Asia Real Estate Tracker

  • Gaw Capital secures $260M investment for Hong Kong CSI Properties, demonstrating confidence in the real estate market.
  • CapitaLand Ascott Trust makes significant acquisition with purchase of 2 Japanese hotels worth $140M, expanding their portfolio.
  • Hines JV embarks on condo complex development on Delhi’s Birla Mills site, reflecting growing investment interest in India’s real estate sector.

Hana Financial: Share Buyback and Cancellation of 400 Billion Won + 50% Total Shareholder Return

By Douglas Kim

  • On 4 February, Hana Financial (086790 KS) announced a share buyback and cancellation of 400 billion won worth of treasury shares, representing 2.3% of its market cap. 
  • Hana Financial plans to achieve a total shareholder return ratio of 50% by 2027. Its total shareholder return ratio increased to 37.8% in 2024, up 4.8% YoY. 
  • Hana Financial’s total cash dividend per common share is 3,600 won in 2024 (up 5.9% YoY). Hana Financial’s total shareholder return ratio increased to 37.8% in 2024, up 4.8% YoY. 

Marsh McLennan: Can Insurance Pricing Cycles Sustain Growth in the Long Run? – Major Drivers

By Baptista Research

  • Marsh & McLennan Companies, a global leader in professional services, closed 2024 with substantial financial growth, registering an 8% revenue increase to $24.5 billion and a 7% underlying revenue growth.
  • The company reported an 11% expansion in adjusted operating income, reaching $6.2 billion against a backdrop of a complex global market.
  • The year’s achievements were attributed not just to core business growth but also to an aggressive acquisition strategy, including a record $9.4 billion in acquisitions with a pivotal $7.75 billion deal to acquire McGriff.

CPKF: Fourth Diluted Quarter EPS beats Our Estimate by a Dime

By Zacks Small Cap Research

  • CPKF’s 2024 fourth quarter net earnings increased $2.1 million, or 236%, to $3.0 million year over year, while diluted EPS rose $0.45, or 235%, to $0.64.
  • This was better than our estimate, which had called for a $1.6 million increase in net earnings to $2.5 and a $0.35 increase in diluted EPS to $0.54.The major reasons for the fourth quarter’s $2.1 million increase in net earnings versus the prior-year quarter were a $1.2 million, or 11%, increase in net interest income and a $1.0 million, or 22%, rise in total noninterest income.
  • For the year, CPKF posted net income of $11.4 million, or $2.42 per diluted share, up $1.3 million, or 13%, from the $10.1 million, or $2.15 per diluted share, posted in 2023.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Kyocera Corp, HD Hyundai Marine Solution , Barito Renewables Energy, Tam Jai International, Vesync, Fuji Soft Inc, Proto Corp, LG CNS, Tecnos Japan, Netmarble and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Kyocera (6971) – Changes Policies – Will Sell KDDI Faster and Buy Back Shares
  • KOSPI200 Index Rebalance Preview: 6 Potential Changes in June; LG CNS Listing Could Increase That
  • Barito Renewables Energy (BREN IJ): Global Index Inclusion Likely This Month
  • Tam Jai (2217 HK) Suspended: Expect Toridoll (3397 JP) To Make An Offer
  • Vesync (2148 HK): Trading Wide Ahead Of The Scheme Vote
  • Fuji Soft (9749 JP): Nearing the Endgame as KKR Bumps to JPY9,850
  • Proto Corp (4298) – MBO After Restatement Scandal Is Opportunistic at ¥2,100 (+64%)
  • LG CNS: First Day Trading Strategy Post IPO
  • Tecnos Japan (3666 JP): Ant Capital’s JPY1,155 Tender Offer
  • Korea: 11 Potential Index Deletions in February


Kyocera (6971) – Changes Policies – Will Sell KDDI Faster and Buy Back Shares

By Travis Lundy

  • Today, in conjunction with the release of Q3 earnings, Kyocera Corp (6971 JP) announced a change in its Corporate Governance Code doc, a change in Cross-holding Policy, and Buyback Policy.
  • Full-Year earnings guidance revision was non-salutary. Revs -1%, OP -69%, Net Profit -72% vs previous predictions from 30 October (those were -1.5%, -38.2%, -36.6% vs April guidance at the time). 
  • Based on this disappointment, they announced they would speed up the sale of crossholdings and buy back shares this year and over the following three years.

KOSPI200 Index Rebalance Preview: 6 Potential Changes in June; LG CNS Listing Could Increase That

By Brian Freitas

  • Halfway through the review period, there could be 6 changes for the Korea Stock Exchange KOSPI200 (KOSPI2 INDEX) in June. The LG CNS (LGCNSZ KS) listing could increase that number.
  • The impact on the potential inclusions ranges from 2.1-26 days of ADV while the impact on the potential deletions varies from 5-11 days of ADV.
  • The forecast adds have outperformed the forecast deletes over the last few months and the performance gap is near its widest point.

Barito Renewables Energy (BREN IJ): Global Index Inclusion Likely This Month

By Brian Freitas

  • Barito Renewables Energy (BREN IJ) stock has gone through a series of gyrations as index inclusion was announced and then retracted due to the concentrated holding of the stock.
  • With pre-IPO PE/VC investors selling some stock, the increase in float could result in the inclusion of Barito Renewables Energy (BREN IJ) in a global index later this month.
  • The inclusion of the stock in the index will require passive trackers to buy just over 400m shares of the stock. That is over 14x ADV and will be impactful.

Tam Jai (2217 HK) Suspended: Expect Toridoll (3397 JP) To Make An Offer

By David Blennerhassett

  • Tam Jai International (2217 HK), an operator of Asia noodle specialty restaurants, is currently suspended pursuant to the Takeovers Code.
  • On the 13th November 2024, Tam Jai announced 1H25 net profit – to 30th September 2024 – declined 55.8% yoy to HK$36.1mn, its lowest six-month tally since listing. 
  • Toridoll Holdings Corporation (3397 JP) controls 74.61% of Tam Jai. Expect a Scheme to unfold. An Offer price around HK$1.50/share would be welcome. That’s probably a stretch.

Vesync (2148 HK): Trading Wide Ahead Of The Scheme Vote

By David Blennerhassett

  • Back on the 27th December, Vesync (2148 HK), a manufacturer of small home appliances, announced an Offer, by way of a Scheme, from the Yang family controlling ~69.04% of Vesync. 
  • The Cancellation Price of $5.60/share, declared final, was a 33.3% premium to undisturbed, and above the 2020 IPO price of HK$5.52/share.
  • The US anti-trust condition has now been fulfilled. The Scheme Doc dispatch has been extended to the 11 April. I estimate payment under the Offer late May. 

Fuji Soft (9749 JP): Nearing the Endgame as KKR Bumps to JPY9,850

By Arun George

  • KKR & Co (KKR US) has increased its Fuji Soft Inc (9749 JP) offer to JPY9,850, a 4.2% premium to the previous JPY9,451 offer and a 2.6% premium to Bain’s JPY9,600 offer.
  • A bump from KKR was expected and necessary, as the shares have consistently traded above its previous offer. Bain is scheduled to launch its competing offer this week. 
  • Expect a final round of bids, as KKR’s offer is not final. The shares closed above KKR’s offer, which remains below the high end of the IFA DCF valuation range. 

Proto Corp (4298) – MBO After Restatement Scandal Is Opportunistic at ¥2,100 (+64%)

By Travis Lundy

  • Proto Corp (4298 JP) is not the name on people’s lips, but everyone who knows cars in Japan knows this company. They have run car mags for decades.
  • Now they do other things too but car magazines, websites, and associated data provision are worth 90% of OP. And they are ubiquitous, and growth has been good. 
  • Management forecasts for growth are a damp squib. This is opportunistic. 

LG CNS: First Day Trading Strategy Post IPO

By Douglas Kim

  • In this insight, we discuss the first day trading strategy of LG CNS which starts trading on 5 February.
  • On the first day of trading, we believe LG CNS’s shares could trade at higher levels, overshooting its intrinsic valuations.
  • We recommend investors to take some profits off the table if the share price shoots higher by 30% to 50%+ from the IPO price on the first day.

Tecnos Japan (3666 JP): Ant Capital’s JPY1,155 Tender Offer

By Arun George

  • Tecnos Japan (3666 JP) has recommended a tender offer from Ant Capital at JPY1,155, a 38.7% premium to the last close.
  • The offer is reasonable as it is above the midpoint of the target IFA’s DCF valuation range and represents a seven-year high.
  • Ant has secured irrevocables from the top three shareholders. However, the largest shareholder’s irrevocable has a counteroffer and share price clause, which could result in a competing bid. 

Korea: 11 Potential Index Deletions in February

By Brian Freitas

  • There are 11 stocks (maybe 12) in Korea that could be deleted from a global index in February and that will result in large selling from passive trackers.
  • With announcement in a week and implementation in just over 3 weeks, there is positioning in a lot of the names.
  • With short selling still banned, positioning will not be as high as the passive selling and the stocks could still drop over the next few weeks.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief ESG: Seeing Disappointing Disclosures Raises Question of What Was the Skill Matrix of Board Directors? and more

By | Daily Briefs, ESG

In today’s briefing:

  • Seeing Disappointing Disclosures Raises Question of What Was the Skill Matrix of Board Directors?


Seeing Disappointing Disclosures Raises Question of What Was the Skill Matrix of Board Directors?

By Aki Matsumoto

  • With about 40% of companies having a P/B of less than 1x, the problem is that many disclosures do not understand management to create value and increase the stock price.
  • It’s difficult for investors’ voices to reach small cap companies and companies with still high defensive walls of cross-held shares, which are not easily targeted for investment by institutional investors.
  • Independent directors should be appointed with skillset to participate in developing management plans and scrutinize them for reasonableness and whether the projected corporate value is gapped from that of investors.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: LG CNS IPO: Trading Debut and more

By | Daily Briefs, ECM

In today’s briefing:

  • LG CNS IPO: Trading Debut
  • LG CNS IPO Trading – Demand Aided by Domestics, Limited Lockup Undertaking
  • Kaynes Technology QIP Early Look – QIP to Fund Global Expansion Plans
  • Sionna Therapeutics, Inc. (SION): Phase I Cystic Fibrosis Biotech Sets Terms for IPO


LG CNS IPO: Trading Debut

By Arun George


LG CNS IPO Trading – Demand Aided by Domestics, Limited Lockup Undertaking

By Clarence Chu

  • LG CNS (LGCNSZ KS) raised around US$825m in its Korea IPO. LG CNS is a South Korean information technology company.
  • LG CNS is a South Korean information technology company. The firm primarily provides comprehensive digital transformation services and solutions backed AI, big data, and cloud.
  • In this note, we will talk about the demand for the deal and other trading dynamics.

Kaynes Technology QIP Early Look – QIP to Fund Global Expansion Plans

By Akshat Shah

  • Kaynes Technology India (KAYNES IN) is looking to raise around US$185m in its upcoming qualified institutional placement (QIP).
  • In an announcement released on Jan 22, 2025, Kaynes had mentioned its board’s approval to raise up to INR16bn via a QIP. Since then, the shares have corrected 8.6%.
  • The deal would not be a large one to digest at 4.3 days of three month ADV. The company’s last fundraise did well.

Sionna Therapeutics, Inc. (SION): Phase I Cystic Fibrosis Biotech Sets Terms for IPO

By IPO Boutique

  • Biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis filed for IPO.
  • The terms value the company between $652m-$734m with the $16-$18 price range.
  • The company’s existing shareholders include some of the best pre-IPO names in the biotech sphere.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Lucror Analytics – Morning Views Asia and more

By | Credit, Daily Briefs

In today’s briefing:

  • Lucror Analytics – Morning Views Asia


Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: West China Cement, Adani Ports, Vedanta Resources, Softbank Group, Tata Motors, UPL Limited
  • In the US, the December personal spending came in above estimates at 0.7% m-o-m (0.5% e / 0.6% revised p), while personal income inched up to 0.4% m-o-m (0.4% e / 0.3% p).
  • Separately, the PCE price index climbed to 2.6% y-o-y (2.6% e / 2.4% p) and 0.3% m-o-m (0.3% e / 0.1% p). That said, the core PCE price index (the Fed’s preferred measure of inflation) was largely stable at 2.8% y-o-y (2.8% e / 2.8% p) and 0.2% m-o-m (0.2% e / 0.1% p).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Ohayo Japan | US and Canada Agree to 30-Day Tariff Pause Amid Border Deal and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Ohayo Japan | US and Canada Agree to 30-Day Tariff Pause Amid Border Deal
  • Economic Survey Highlights Potential Risk for the Indian Stock Market
  • Japan Morning Connection: Trump Tariff U-Turn Will Help Markets Start Better
  • Thematic Report: Impact of Indian Budget 2025 on Sectors and Companies
  • India: Monthly Insider Buying Update – January 2025
  • Charted Insights: How Rising Per Capita Incomes Shape Discretionary Consumption in India?
  • Singapore Market Roundup (03-Feb-2025): DBS reports Feb 10, Maybank predicts surprises.
  • 96# India Insight: Rashmi Saluja Sues Religare, JSW Energy Revises Capex, Budget 2025 Highlights.
  • Thematic Report: Indian Shrimp Industry: Changing Fortunes
  • Monday Delight: 27/01/25


Ohayo Japan | US and Canada Agree to 30-Day Tariff Pause Amid Border Deal

By Mark Chadwick

  • US and Canada announced a 30-day pause on planned 25% tariffs late Monday, following a phone call between President Donald Trump and Prime Minister Justin Trudeau.
  • Consumer discretionary and tech stocks lagged, with Nvidia, Apple, and Tesla all sliding over 2.5%.
  • SoftBank Group and OpenAI have announced a partnership to develop and market “Cristal intelligence,” an Advanced Enterprise AI solution.

Economic Survey Highlights Potential Risk for the Indian Stock Market

By Nimish Maheshwari

  • The Economic Survey highlighted potential risks to India’s stock market in 2025 due to high valuations and optimistic sentiments in the US. 
  • India’s growing retail investor base adds resilience, but many new investors lack experience with market corrections, increasing vulnerability to US market downturns.
  • The survey highlights the historical correlation between Indian and US equities, noting that Nifty 50 declined in 21 out of 22 instances when the S&P 500 corrected by over 10%

Japan Morning Connection: Trump Tariff U-Turn Will Help Markets Start Better

By Andrew Jackson

  • Weak tape for tech over mixed signalling out of White House.
  • Kyocera earnings missed but management seem to be pulling the right levers (finally) on the restructuring front.
  • Ibiden tarred by the Shinko brush, but what about its NVDA exposure?

Thematic Report: Impact of Indian Budget 2025 on Sectors and Companies

By Nimish Maheshwari

  • Budget FY26 treads a fine balance between promoting consumption without compromising on fiscal prudence and maintaining continuity on capex.  
  • This report highlights the sector and stock-specific impact of announcements
  • Nifty50 EPS growth will remain tepid but it could be much better in FY26E. Post the double-digit market correction, Nifty50 large caps seem less expensive (trading at < +1 sd).

India: Monthly Insider Buying Update – January 2025

By Sreemant Dudhoria

  • Insider buying activity often signals that a positive shift in the business cycle may be approaching for certain businesses.
  • As January 2025 was a month of earnings season,very few companies reported insider transactions. However,given the correction in Indian market,we should expect increased buy transactions once the earnings season concludes.
  • Cyient Ltd (CYL IN) witnessed significant buying by the company’s promoters

Charted Insights: How Rising Per Capita Incomes Shape Discretionary Consumption in India?

By Nimish Maheshwari

  • Economic growth leads to increased discretionary consumption, with higher income levels driving demand for a broader and more sophisticated range of consumer goods. 
  • This pattern suggests opportunities for businesses to innovate and expand their offerings as economies develop.
  • With economic progress and higher incomes (US$ 5,000 and beyond), consumers begin to spend more on mobility and durable goods.

Singapore Market Roundup (03-Feb-2025): DBS reports Feb 10, Maybank predicts surprises.

By Singapore Market Roundup

  • DBS to kick off bank results on Feb 10, emphasis on capital management; Maybank anticipates surprises from DBS and UOB.
  • DBS maintained ‘buy’, while OCBC downgraded Starhill Global REIT to ‘hold’ after 1HFY2025 results, resulting in a lowered TP.
  • DBS raised Yangzijiang Shipbuilding’s TP to $3.80 due to improved margins and robust orderbook, reflecting an upgrade.

96# India Insight: Rashmi Saluja Sues Religare, JSW Energy Revises Capex, Budget 2025 Highlights.

By Sudarshan Bhandari

  • Rashmi Saluja, CEO and Chairperson of Religare Enterprises (RELG IN) , sues the company to prevent a potential takeover by the Burman family. (promoter family of Dabur India Ltd (DABUR IN))
  • JSW Energy Ltd (JSW IN)  revises its FY25 capex target to Rs 10,000 crore, down from Rs 15,000 crore, shifting focus to acquisitions due to sectoral constraints.
  • The Union Budget 2025 allocates Rs. 6.81 lakh crore to defence, with Rs. 4.88 lakh crore for revenue and Rs. 1.92 lakh crore for capital expenditure.

Thematic Report: Indian Shrimp Industry: Changing Fortunes

By Nimish Maheshwari

  • The shrimp industry is recovering from a prolonged slump as Ecuador’s production declines due to power cuts and drought, and India’s adverse weather impacts yield.
  • India’s shrimp exports, critical to its seafood trade, are poised to benefit from higher global prices, a recovery in Western demand, and favorable domestic production conditions.
  • Rising prices and demand create optimism for India’s shrimp producers, but challenges like competition from Ecuador, cost pressures, and geopolitical risks remain. 

Monday Delight: 27/01/25

By Contrarian Cashflows

  • Welcome back to Monday Delights!
  • This is your Monday morning dose of inspiration. Each week, I’ll share five intriguing investment ideas that recently caught my attention. These ideas are meant to spark your research and help you kickstart the week ahead with fresh insights.
  • The ideas will often be concise, with occasional references to valuable work from other practitioners that I encourage you to explore.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Kyocera (6971) – Changes Policies – Will Sell KDDI Faster and Buy Back Shares and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Kyocera (6971) – Changes Policies – Will Sell KDDI Faster and Buy Back Shares
  • Lee Jae-Yong’s Appeal Verdict: Unpacking the Drivers Behind Samsung Life’s Big Price Action
  • Vesync (2148 HK): Antitrust Condition Satisfied, and the Scheme Vote Remains Low-Risk
  • KOSPI200 Index Rebalance Preview: 6 Potential Changes in June; LG CNS Listing Could Increase That
  • SelfWealth (SWF AU): Peter Thiel-Backed Svava Crashes Bell’s Offer
  • EQD | Nifty Index Options Weekly (Jan 24 – 31): Second Longest Decline Since 2007
  • Vesync (2148 HK): Trading Wide Ahead Of The Scheme Vote
  • Daemyung Sono Group May Wage a Public Opinion War for T’Way Air
  • EQD | Nikkei Index Options Weekly (January 27 – 31): USD/JPY and Nikkei at a Stalemate
  • Weekly Update (APTV, MRP, MEDXF, AAF, WDC)


Kyocera (6971) – Changes Policies – Will Sell KDDI Faster and Buy Back Shares

By Travis Lundy

  • Today, in conjunction with the release of Q3 earnings, Kyocera Corp (6971 JP) announced a change in its Corporate Governance Code doc, a change in Cross-holding Policy, and Buyback Policy.
  • Full-Year earnings guidance revision was non-salutary. Revs -1%, OP -69%, Net Profit -72% vs previous predictions from 30 October (those were -1.5%, -38.2%, -36.6% vs April guidance at the time). 
  • Based on this disappointment, they announced they would speed up the sale of crossholdings and buy back shares this year and over the following three years.

Lee Jae-Yong’s Appeal Verdict: Unpacking the Drivers Behind Samsung Life’s Big Price Action

By Sanghyun Park

  • Once Samsung F&M burns treasury shares, Samsung Life’s stake hits 16.93%. If they avoid a subsidiary, they’ll need to dump ~817K shares. Today’s ruling makes that move much less likely.
  • Samsung Life’s value-up announcement could be major, likely dropping around their earnings call on February 20, with solid intel backing this move.
  • The balance of dividends vs. buybacks, plus Samsung Life’s 10% stake ceiling, will drive volatility for Samsung Electronics. Samsung Life’s value-up release, before Samsung Electronics’, will boost market clarity.

Vesync (2148 HK): Antitrust Condition Satisfied, and the Scheme Vote Remains Low-Risk

By Arun George

  • On 27 December 2024, Vesync (2148 HK) disclosed a Cayman scheme privatisation offer from the Yang family at HK$5.60. On 28 January, the antitrust condition was satisfied.   
  • Despite a light offer, the scheme vote is low-risk. No disinterested shareholder holds a blocking stake, there is a scrip option with no cap, and there is no retail opposition. 
  • The scheme document will be despatched by 11 April. At the last close and for an end-of-May payment, the gross and annualised spread is 6.9% and 22.7%, respectively.  

KOSPI200 Index Rebalance Preview: 6 Potential Changes in June; LG CNS Listing Could Increase That

By Brian Freitas

  • Halfway through the review period, there could be 6 changes for the Korea Stock Exchange KOSPI200 (KOSPI2 INDEX) in June. The LG CNS (LGCNSZ KS) listing could increase that number.
  • The impact on the potential inclusions ranges from 2.1-26 days of ADV while the impact on the potential deletions varies from 5-11 days of ADV.
  • The forecast adds have outperformed the forecast deletes over the last few months and the performance gap is near its widest point.

SelfWealth (SWF AU): Peter Thiel-Backed Svava Crashes Bell’s Offer

By David Blennerhassett

  • On the 25th November, online trading player SelfWealth Ltd (SWF AU) entered into a SID with Bell Financial (BFG AU) at A$0.25/share after outbidding AxiCorp Financial Services.
  • Now Singaporean-based wealth manager Svava has tabled a non-binding A$0.28/share Offer, in cash, by way of a Scheme. Svava also holds an effective blocking stake – 18.8% of shares out. 
  • SelfWealth said Svava’s proposal “while indicative and non-binding, could be reasonably considered to become a superior proposal.” BFG needs to step up. 

EQD | Nifty Index Options Weekly (Jan 24 – 31): Second Longest Decline Since 2007

By John Ley

  • Nifty has been in a prolonged downtrend, currently 4 months in duration and clipping 10.3% off the index. This is the second longest decline since 2007.
  • When looked at vs the extent of this decline, implied vol is at the bottom of its historical range and historic vol also quietest in a down-move since 2007.
  • Implied vol is trading at or above peak levels seen on historic vol since the decline started and implied remains negatively correlated to movements in spot.

Vesync (2148 HK): Trading Wide Ahead Of The Scheme Vote

By David Blennerhassett

  • Back on the 27th December, Vesync (2148 HK), a manufacturer of small home appliances, announced an Offer, by way of a Scheme, from the Yang family controlling ~69.04% of Vesync. 
  • The Cancellation Price of $5.60/share, declared final, was a 33.3% premium to undisturbed, and above the 2020 IPO price of HK$5.52/share.
  • The US anti-trust condition has now been fulfilled. The Scheme Doc dispatch has been extended to the 11 April. I estimate payment under the Offer late May. 

Daemyung Sono Group May Wage a Public Opinion War for T’Way Air

By Douglas Kim

  • In the past two trading days, share prices of T’Way Air (091810 KS) and T’Way Holdings (004870 KS) are down 16.4% and 14.1%, respectively.
  • According to Hankyung daily, Daemyung Sono Group Chairman Seo may choose to wage a public opinion war, instead of purchasing additional shares.  
  • If Daemyung Sono Group is unable to take over the management control of T’Way Air using this method, then a potential tender offer of T’Way Air is possible later on. 

EQD | Nikkei Index Options Weekly (January 27 – 31): USD/JPY and Nikkei at a Stalemate

By John Ley

  • This week we add in some additional graphs and commentary highlighting USD/JPY vs Nikkei 225.
  • Implied vols were very reactive to spot to open the week with Nikkei dropping almost 1% on Monday.
  • Heavier volume on the down days with Puts making up 57.8% of the total weekly volume.

Weekly Update (APTV, MRP, MEDXF, AAF, WDC)

By Richard Howe

  • There were no new spin-off announcements this week, but I’ve done some more work on the Aptiv (APTV) spin-off announcement.

  • Aptiv PLC (APTV), an automotive technology supplier, announced on January 22, 2025, that it plans to split into two distinct companies.

  • Aptiv will spin-off its electrical systems business. The RemainCo will concentrate on technological components, including sensor-to-cloud solutions and autonomous driving software.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: Jeffrey Emanuel: Viral Author of The Short Case for Nvidia Stock – cohosted by Pondering Durian and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Jeffrey Emanuel: Viral Author of The Short Case for Nvidia Stock – cohosted by Pondering Durian
  • Lots More with Matt Levine on MicroStrategy’s Infinite Money Machine
  • Didi Global Inc (DIDIY) – Sunday, Nov 3, 2024
  • Lasertec: FY25 Guidance Isn’t Revised up Despite a Blockbuster 2Q25. The Stock Is Attractive.
  • HK-Listed Apparel & Footwear Screener: Parsing Lever Styles (1346 HK) Profit Alert
  • Korea Small Cap Gem #32: Pulmuone
  • Tech Supply Chain Tracker (03-Feb-2025): India building own AI model by 2025
  • Celestica Inc: Will The Expansion in Liquid Cooling Technologies Act As A Key Growth Enabler? – Major Drivers
  • Sumitomo Pharma (4506 JP): Robust 9MFY25 Revenues; Back in Black; Guidance Revised
  • Daiichi Sankyo (4568 JP): Mixed Q3FY25 Result; FY25 Net Profit Guidance Raised; New CEO Appointed


Jeffrey Emanuel: Viral Author of The Short Case for Nvidia Stock – cohosted by Pondering Durian

By The Delphi Podcast

  • Market value of stocks close to 2 trillion, including Nvidia at 600 billion
  • Author missed opportunity to short Nvidia despite strong case outlined in article
  • Concerns about competition, margins, and custom chips impacting Nvidia’s growth potential

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Lots More with Matt Levine on MicroStrategy’s Infinite Money Machine

By Odd Lots

  • Stifel is a leading middle market investment bank with a large equity research franchise
  • Stifel has won the J.D. Power Award for Employee Advisor satisfaction two years in a row
  • The Odd Lots podcast discusses topics like MicroStrategy’s perpetual motion machine and leveraged bitcoin investments

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Didi Global Inc (DIDIY) – Sunday, Nov 3, 2024

By Value Investors Club

  • Didi Global Inc. is a prominent mobility technology platform offering ride hailing, taxi hailing, and ride sharing services
  • The company dominates the market in China and Latin America, especially in Brazil and Mexico
  • Didi also has other initiatives including E-bike sharing, energy and vehicle services, intra-city freight, autonomous driving, and financial services.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Lasertec: FY25 Guidance Isn’t Revised up Despite a Blockbuster 2Q25. The Stock Is Attractive.

By Nicolas Baratte

  • After 2 very poor quarters (revenue decline YoY), 2Q25 revenue increase 93% YoY, net income 137%. The painfully high volatility will not go away. 
  • But Lasertec maintains its FY25 guidance which means that the blowout 2Q25 does not indicate higher growth
  • The expectation bubble should have completely deflated (SiC for EV, Intel, Samsung). The stock is trading at 18x, at the bottom of its trading range and valuations. Attractive.

HK-Listed Apparel & Footwear Screener: Parsing Lever Styles (1346 HK) Profit Alert

By Sameer Taneja


Korea Small Cap Gem #32: Pulmuone

By Douglas Kim

  • Pulmuone has benefited from improved sales and profitability of its US subsidiary, driven by higher demand for Korean foods and plant based/non-meat based foods such as tofu.
  • The company has nearly 70% market share in the tofu segment in the US. It has gained meaningful economies of scale of its tofu product in the United States. 
  • Pulmuone currently has a market cap of 390 billion won. Using the consensus net profit estimate of 37.6 billion won, this would suggest a P/E of 10.3x.

Tech Supply Chain Tracker (03-Feb-2025): India building own AI model by 2025

By Tech Supply Chain Tracker

  • India aims to create its own foundational model by 2025, showing its commitment to technological development and innovation.
  • DeepSeek’s founder’s journey from stock prodigy to AI disruptor highlights the potential for growth and success in the tech industry.
  • Cadence’s focus on expanding in India’s data center industry shows the increasing importance of this sector in the global economy.

Celestica Inc: Will The Expansion in Liquid Cooling Technologies Act As A Key Growth Enabler? – Major Drivers

By Baptista Research

  • Celestica’s fourth-quarter 2024 financial performance illustrates a complex landscape with both impressive achievements and areas of strategic caution.
  • The company reported strong revenue growth, reaching $2.55 billion, aligning with the high end of its guidance.
  • Adjusted earnings per share (EPS) surpassed expectations, recording $1.11, reflecting the company’s robust operational capabilities.

Sumitomo Pharma (4506 JP): Robust 9MFY25 Revenues; Back in Black; Guidance Revised

By Tina Banerjee

  • Sumitomo Pharma (4506 JP) reported 25% YoY revenue growth during 9MFY25, driven by North America.
  • Restructuring and streamlining efforts help curb expenses and post a core operating profit of ¥21B during 9MFY25 compared to an operating loss of ¥96B in same period last year.
  • Sumitomo is now expecting FY25 revenue to be ¥381B, up by ¥43B from the previous forecast and a core net profit of ¥16B.

Daiichi Sankyo (4568 JP): Mixed Q3FY25 Result; FY25 Net Profit Guidance Raised; New CEO Appointed

By Tina Banerjee

  • Daiichi Sankyo (4568 JP) reported mixed Q3FY25 result, with revenue increasing 8% YoY to ¥484.8M and net profit decreasing 7% YoY to ¥61.9M. Enhertu revenue increased 39% YoY to ¥143B.
  • The company has raised FY25 net profit guidance by 7% to ¥240B (up 20% YoY), to reflect an increase in financial income due to an improvement in foreign exchange gains.
  • As Daiichi Sankyo enters the final year of its current five-year business plan, the company has appointed Hiroyuki Okuzawa as Chief Executive Officer effective April 1, 2025.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars